Global Insulin Delivery Devices Market: A CAGR of 7% Estimated over 2014-2020, North America to Remain Largest Market

Latest industry research report on: Global Insulin Delivery Devices Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts


Albany, NY -- (SBWIRE) -- 09/08/2017 -- The global insulin delivery devices market report provides in-depth analysis and estimation of the insulin delivery devices market from 2014 to 2020, considering 2014 as the base year for calculation of all the market values. Additionally, data pertaining to current market dynamics, including market drivers, restraints, trends, recent developments, and upcoming opportunities in the market, has been provided in the global insulin delivery devices market report. The drivers section elaborates key factors that may bolster the market growth during the forecast period, whereas the restraints section provides an extensive analysis of some important factors that are anticipated to negatively influence the market growth.

Request For Sample Report @

The next part of the report offers value-added information on the latest trends in the global insulin delivery devices market and the upcoming opportunities that may prove to be profitable for stakeholders in the market, over the aforementioned forecast period. The report further bifurcates the market into various segments based on the type of insulin delivery device. There are four key segments, which are further sub-segmented. Each of them is exhaustively studied, examined, and elaborated to reveal the consumption pattern, growth rates, market shares, and growth prospects. The next section is of regional analysis based on the geography. The report assesses all regional markets with equal emphasis and helps to understand their individual growth dynamics along with potential opportunities in each of them.

Some of the major players operating in the market are Abbott Laboratories, Novo Nordisk A/S, Eli Lilly and Company, Medtronic, Inc., Sanofi, Becton, Dickinson and Company, and F. Hoffmann-La Roche, Ltd. The global insulin delivery devices market report's key market players section provides in-depth profiles of these key companies on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, financial overview, and estimated market share.

View Sample PDF @

Research Methodology

To deduce the global insulin delivery devices market size, the report considers various aspects based on secondary research. Furthermore, key data points such as region-wise split and market split by product type, vehicle type, and distribution channel; and qualitative inputs from primary respondents have been incorporated to arrive at appropriate market estimates. The forecast presented in the report assesses the total revenue generated and expected revenue contribution in the global insulin delivery devices market.

The report begins with sizing the market in terms of value and volume for the base year, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, gathered data is triangulated via different analysis based on supply side and demand side drivers and other key dynamics of the global insulin delivery devices market. To develop the market forecast, Persistence Market Research has also conducted a factor analysis to understand the impact of various forces/factors on the target market. The report provides forecasts not only in terms of CAGR but also presents a detailed analysis based on key parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities.

Have Any Query? Ask Our Expert @

Another key feature of this report is an analysis of the global insulin delivery devices market and the corresponding revenue forecast in terms of absolute dollar opportunity, usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global insulin delivery devices market. Further, to understand key segments in terms of their growth and overall global insulin delivery devices market performance, Persistence Market Research has developed a market attractiveness index to help providers identify existing market opportunities in the global insulin delivery devices market.

Some of the major players operating in the market:

Abbott Laboratories.

Novo Nordisk A/S.

Eli Lilly and Company.

Medtronic, Inc.

Sanofi, Becton.

Dickinson and Company.

F. Hoffmann-La Roche, Ltd.


About is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074